We are live on ! Find out more
HCA icon

HCA Healthcare

1,000 hedge funds and large institutions have $41.6B invested in HCA Healthcare in 2023 Q3 according to their latest regulatory filings, with 106 funds opening new positions, 360 increasing their positions, 369 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less repeat investments, than reductions

Existing positions increased: 360 | Existing positions reduced: 369

4% less first-time investments, than exits

New positions opened: 106 | Existing positions closed: 110

1.09% less ownership

Funds ownership: 63.06%61.97% (-1.1%)

1% less funds holding

Funds holding: 1,0131,000 (-13)

11% less call options, than puts

Call options by funds: $509M | Put options by funds: $572M

21% less capital invested

Capital invested by funds: $52.6B → $41.6B (-$11B)

28% less funds holding in top 10

Funds holding in top 10: 3626 (-10)

Holders
1,000
Holders Change
-13
Holders Change %
-1.28%
% of All Funds
15.87%
Holding in Top 10
26
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-27.78%
% of All Funds
0.41%
New
106
Increased
360
Reduced
369
Closed
110
Calls
$509M
Puts
$572M
Net Calls
-$63.1M
Net Calls Change
-$80.9M
Name Holding Trade Value Shares
Change
Change in
Stake
X
276
Xponance
Pennsylvania
$7.05M -$6.29K -23 -0.1%
Allspring Global Investments
277
Allspring Global Investments
North Carolina
$6.93M -$1.93M -7,050 -20%
AFWM
278
AMJ Financial Wealth Management
Virginia
$6.78M +$138K +503 +2%
PCM
279
Prelude Capital Management
New York
$6.73M +$5.5M +20,086 +276%
PGCM
280
Prescott Group Capital Management
Oklahoma
$6.67M
LGF
281
LGT Group Foundation
Liechtenstein
$6.48M +$564K +2,060 +9%
WBC
282
Westpac Banking Corp
Australia
$6.46M -$1.23M -4,491 -15%
NCM
283
Narwhal Capital Management
Georgia
$6.27M -$606K -2,216 -8%
SCM
284
Sirios Capital Management
Massachusetts
$6.25M -$477K -1,742 -6%
RFC
285
Regions Financial Corp
Alabama
$6.21M +$10.4K +38 +0.2%
YCM
286
Yousif Capital Management
Michigan
$6.18M -$387K -1,416 -5%
JFG
287
Jefferies Financial Group
New York
$6.15M +$5.2M +19,020 +317%
MML Investors Services
288
MML Investors Services
Massachusetts
$6.12M +$1.92M +7,033 +39%
RJT
289
Raymond James Trust
Florida
$6.11M -$150K -547 -2%
NAM
290
Nissay Asset Management
Japan
$6.11M +$228K +833 +3%
FC
291
FORA Capital
Florida
$6.1M +$6.78M +24,786 New
Commonwealth Equity Services
292
Commonwealth Equity Services
Massachusetts
$6.09M +$41.3K +151 +0.6%
RG
293
Redmile Group
California
$6.07M +$6.75M +24,667 New
FGA
294
Fortis Group Advisors
New Jersey
$6.02M +$92.5K +338 +2%
AIM
295
Achmea Investment Management
Netherlands
$6M +$804K +2,938 +14%
GAM
296
Gotham Asset Management
New York
$5.98M +$155K +565 +2%
SMDAM
297
Sumitomo Mitsui DS Asset Management
Japan
$5.96M -$4.11K -15 -0.1%
HC
298
Hourglass Capital
Texas
$5.93M -$102K -373 -2%
SOADOR
299
State of Alaska Department of Revenue
Alaska
$5.88M -$450K -1,645 -6%
CI Investments Inc
300
CI Investments Inc
Ontario, Canada
$5.79M -$963K -3,521 -13%

HCA Hedge Fund Activity: Q3 2023 in Review

1,000 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q3 2023, worth a combined $41.6B — down 21% from $52.6B a quarter earlier.

Sellers outnumbered buyers: 110 funds closed out of HCA and 106 opened new positions — a net loss of 4 holders — while 369 trimmed existing stakes and 360 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $229M. The largest seller was T. Rowe Price Associates, cutting an estimated $717M.

  • 1,000 institutional investors held HCA Healthcare (HCA) as of Q3 2023, down from 1,013 in Q2 2023.
  • Funds reported $41.6B of HCA Healthcare stock for Q3 2023, down 21% quarter-over-quarter.
  • 106 funds opened new HCA Healthcare positions in Q3 2023 and 110 closed out, a net change of -4 holders.
  • The largest HCA Healthcare buyer in Q3 2023 was Capital World Investors, an estimated $229M added.
  • The largest HCA Healthcare seller in Q3 2023 was T. Rowe Price Associates, an estimated $717M sold.

Based on aggregated 13F filings for Q3 2023.